Alcidion Group

Alcidion Group Share Buybacks

Share Buybacks of Alcidion Group (ALC.AX) as of Nov 11, 2026.

Share Buybacks

0.00AUD

Last updated:

Share Buybacks of Alcidion Group is 2025 0.00 AUD. Share Buybacks of Alcidion Group was 2024 -399,000.00 AUD. It decreases by % higher compared to the previous year.

The Alcidion Group Share Buybacks history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Share Buybacks
Date
Share Buybacks
Jan 1, 2017
225,000.00 AUD
Jan 1, 2018
0.00 AUD
Jan 1, 2020
15.36 M AUD
Jan 1, 2021
17.50 M AUD
Jan 1, 2022
51.94 M AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
-399,000.00 AUD
Jan 1, 2025
0.00 AUD
The Alcidion Group Share Buybacks history
YEARShare BuybacksYoY
0.00AUD-100.00%
-399,000.00AUD—
0.00AUD-100.00%
51.94 MAUD+196.78%
17.50 MAUD+13.93%
15.36 MAUD—
0.00AUD-100.00%
225,000.00AUD-67.03%
682,500.00AUD0.00%
682,500.00AUD0.00%
682,500.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alcidion Group Stock analysis

What does Alcidion Group do? Alcidion Group Ltd. generates revenue through the development and licensing of its healthcare software products, including Miya Precision, Miya Observations, Flow, Task Management, and PAS, marketed under the Miya brand. The company also resells selected healthcare software from strategic partners and provides implementation, support, maintenance, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its flagship product Miya Precision, a FHIR-event platform-based solution, supports clinical and operational applications, while Smartpage offers hospital communication and task management via smartphone and web. The firm serves over 400 hospitals across its key markets. Miya Precision and its associated modules form the core of Alcidion's product portfolio, targeting hospitals seeking integrated clinical solutions. Smartpage, Patientrack, and Silverlink PCS complement these offerings, catering to diverse healthcare communication and operational needs. The company’s revenue streams are driven by direct sales of software licenses, ongoing service contracts, and partner resales, with a focus on the Australian, New Zealand, and UK healthcare sectors. Alcidion’s business model emphasizes software licensing and service delivery, with Miya Precision as the primary revenue generator. The company’s strategic partnerships enable it to resell third-party software, expanding its product range without additional development costs. Healthcare institutions in Australia, New Zealand, and the United Kingdom are the primary buyers, leveraging Alcidion’s solutions for improved clinical workflows and operational efficiency. Alcidion Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alcidion Group stock

On Eulerpool you can find the complete historical development of Share Buybacks Alcidion Group since 2006 – with annual values, charts, and detailed analysis.

Share buybacks represent the cash spent repurchasing the company's own shares. Buybacks reduce shares outstanding and can increase EPS.

Share Buybacks's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Share Buybacks's Alcidion Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Alcidion Group

All Key Metrics — Alcidion Group